Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
Estimates Beat
|
Mid-range Performer
1220.0000
12.90
(
1.07
%)
NSE
May 14, 2025
15:31 PM
Volume:
1.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
01 Nov 2022
Estimates Beat
1220.00
1.07%
Result Update:Dr Reddys Labs
Buy:
Dr. Reddy's Laboratories Ltd.
by
Axis Direct
Target: 5000
Target
Axis Direct
We recommend a BUY rating on the stock with a TP of Rs 5,000/share.
KRChoksey increased Accumulate price target of Dr. Reddy's Laboratories Ltd. to 1324.0 on 13 May, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market closes higher, HAL's Q4 revenue beats Forecaster estimates by 13.5%
Trendlyne Marketwatch |
14 May 2025, 03:55PM
Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs
The Baseline |
14 May 2025, 09:48AM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021